Last 12 months
Inside the activity.
0 purchase rows · 71 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 7 |
| Dec 2025 | 0 | 10 |
| Jan 2026 | 0 | 4 |
| Feb 2026 | 0 | 7 |
| Mar 2026 | 0 | 4 |
| Apr 2026 | 0 | 6 |
| May 2026 | 0 | 4 |
| Jun 2026 | 0 | 6 |
| Jul 2026 | 0 | 4 |
| Aug 2026 | 0 | 10 |
| Sep 2026 | 0 | 7 |
| Oct 2026 | 0 | 2 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 05, 2026 Filed Mar 9, 2026 20:07 UTC |
Gault CherylChief Operating Officer
|
SaleCommon Stock | 2,014 | $28.93 | $58,265.02 |
DisclosureSEC source: 0001193125-26-098488 · ownership.xml · nonDerivative · entry 1 Gault Cheryl · CIK 0001839046 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 169,914 F1 · kind: Represents shares of common stock sold to satisfy taxes associated with the vesting of a restricted stock unit award previously granted to the Reporting Person. Such sales do not represent a discretionary trade by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.34 to $28.94. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| February 19, 2026 Filed Feb 19, 2026 19:05 UTC |
Bredt DavidChief Scientific Officer
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $1.80 | $0.00 |
DisclosureSEC source: 0001193125-26-059883 · ownership.xml · derivative · entry 5 Bredt David · CIK 0002022087 · Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 88,080 Underlying: Common Stock · 6,000 shares Expires 2033-12-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: 25% of the shares underlying this option vested and became exercisable on August 7, 2024, with the remaining shares vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| February 19, 2026 Filed Feb 19, 2026 19:05 UTC |
Bredt DavidChief Scientific Officer
|
Exercise / conversionCommon Stock | 6,000 | $1.80 | $10,800.00 |
DisclosureSEC source: 0001193125-26-059883 · ownership.xml · nonDerivative · entry 4 Bredt David · CIK 0002022087 · Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 393,075 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · kind: Transaction involved a cash exercise of options to purchase shares of the Issuer's common stock. No shares of the Issuer's common stock were sold as part of this transaction. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 00:06 UTC |
Ceesay AbrahamDirector · Chief Executive Officer
|
SaleCommon Stock | 2,100 | $29.80 | $62,572.65 |
DisclosureSEC source: 0001193125-26-059886 · ownership.xml · nonDerivative · entry 4 Ceesay Abraham · CIK 0001722140 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By Dorothy Ceesay Irrevocable Trust Disclosed balance after: 20,729 F1 · kind: These transactions were effected by the Reporting Person pursuant to Rule 10b5-1 trading plans adopted on December 12, 2024. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $29.52 to $30.09, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. F6 · ownership.nature: Shares held by The Dorothy Ceesay Irrevocable Trust u/d/t dated March 27, 2024. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that he is a beneficial owner of such shares for the purpose of Section 16 of the Exchange Act, or for any other purpose. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 00:06 UTC |
Ceesay AbrahamDirector · Chief Executive Officer
|
SaleCommon Stock | 2,983 | $29.04 | $86,639.15 |
DisclosureSEC source: 0001193125-26-059886 · ownership.xml · nonDerivative · entry 3 Ceesay Abraham · CIK 0001722140 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By Dorothy Ceesay Irrevocable Trust Disclosed balance after: 22,829 F1 · kind: These transactions were effected by the Reporting Person pursuant to Rule 10b5-1 trading plans adopted on December 12, 2024. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.51 to $29.49, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. F6 · ownership.nature: Shares held by The Dorothy Ceesay Irrevocable Trust u/d/t dated March 27, 2024. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that he is a beneficial owner of such shares for the purpose of Section 16 of the Exchange Act, or for any other purpose. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 00:06 UTC |
Ceesay AbrahamDirector · Chief Executive Officer
|
SaleCommon Stock | 2,281 | $29.80 | $67,969.92 |
DisclosureSEC source: 0001193125-26-059886 · ownership.xml · nonDerivative · entry 2 Ceesay Abraham · CIK 0001722140 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 556,247 F1 · kind: These transactions were effected by the Reporting Person pursuant to Rule 10b5-1 trading plans adopted on December 12, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $29.56 to $30.08 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 00:06 UTC |
Ceesay AbrahamDirector · Chief Executive Officer
|
SaleCommon Stock | 3,552 | $29.05 | $103,191.28 |
DisclosureSEC source: 0001193125-26-059886 · ownership.xml · nonDerivative · entry 1 Ceesay Abraham · CIK 0001722140 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 558,528 F1 · kind: These transactions were effected by the Reporting Person pursuant to Rule 10b5-1 trading plans adopted on December 12, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.51 to $29.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 19:05 UTC |
Bredt DavidChief Scientific Officer
|
SaleCommon Stock | 2,200 | $29.59 | $65,107.68 |
DisclosureSEC source: 0001193125-26-059883 · ownership.xml · nonDerivative · entry 3 Bredt David · CIK 0002022087 · Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 387,075 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 12, 2024. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $29.45 to $29.81, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 19:05 UTC |
Bredt DavidChief Scientific Officer
|
SaleCommon Stock | 5,400 | $28.95 | $156,328.38 |
DisclosureSEC source: 0001193125-26-059883 · ownership.xml · nonDerivative · entry 2 Bredt David · CIK 0002022087 · Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 389,275 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 12, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.40 to $29.36, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 19:05 UTC |
Bredt DavidChief Scientific Officer
|
SaleCommon Stock | 900 | $28.02 | $25,218.99 |
DisclosureSEC source: 0001193125-26-059883 · ownership.xml · nonDerivative · entry 1 Bredt David · CIK 0002022087 · Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 394,675 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 12, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.39 to $28.30, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 16:09 UTC |
Bredt DavidChief Scientific Officer
|
GrantStock Option (Right to Buy) · Derivative | 103,000 | $0.00 Strike: $27.75 | $0.00 |
DisclosureSEC source: 0001193125-26-037570 · ownership.xml · derivative · entry 1 Bredt David · CIK 0002022087 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,000 Underlying: Common Stock · 103,000 shares Expires 2036-02-02 F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable in forty-eight (48) equal monthly installments following January 1, 2026, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 21:11 UTC |
Yeleswaram KrishnaswamyChief Development Officer
|
GrantStock Option (Right to Buy) · Derivative | 120,000 | $0.00 Strike: $27.75 | $0.00 |
DisclosureSEC source: 0001193125-26-037581 · ownership.xml · derivative · entry 1 Yeleswaram Krishnaswamy · CIK 0002022156 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock · 120,000 shares Expires 2036-02-02 F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable in forty-eight (48) equal monthly installments following January 1, 2026, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 21:15 UTC |
Sevigny JeffreyChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 130,000 | $0.00 Strike: $27.75 | $0.00 |
DisclosureSEC source: 0001193125-26-037618 · ownership.xml · derivative · entry 1 Sevigny Jeffrey · CIK 0001778483 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 130,000 Underlying: Common Stock · 130,000 shares Expires 2036-02-02 F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable in forty-eight (48) equal monthly installments following January 1, 2026, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 21:14 UTC |
Ceesay AbrahamDirector · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 428,000 | $0.00 Strike: $27.75 | $0.00 |
DisclosureSEC source: 0001193125-26-037603 · ownership.xml · derivative · entry 1 Ceesay Abraham · CIK 0001722140 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 428,000 Underlying: Common Stock · 428,000 shares Expires 2036-02-02 F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable in forty-eight (48) equal monthly installments following January 1, 2026, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 21:12 UTC |
Ignelzi Troy A.Chief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 148,000 | $0.00 Strike: $27.75 | $0.00 |
DisclosureSEC source: 0001193125-26-037587 · ownership.xml · derivative · entry 1 Ignelzi Troy A. · CIK 0001579829 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 148,000 Underlying: Common Stock · 148,000 shares Expires 2036-02-02 F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable in forty-eight (48) equal monthly installments following January 1, 2026, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 21:02 UTC |
Gault CherylChief Operating Officer
|
GrantStock Option (Right to Buy) · Derivative | 132,000 | $0.00 Strike: $27.75 | $0.00 |
DisclosureSEC source: 0001193125-26-037529 · ownership.xml · derivative · entry 1 Gault Cheryl · CIK 0001839046 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 132,000 Underlying: Common Stock · 132,000 shares Expires 2036-02-02 F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable in forty-eight (48) equal monthly installments following January 1, 2026, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| January 20, 2026 Filed Jan 23, 2026 00:00 UTC |
Ceesay AbrahamDirector · Chief Executive Officer
|
SaleCommon Stock | 5,083 | $26.11 | $132,737.46 |
DisclosureSEC source: 0001193125-26-019820 · ownership.xml · nonDerivative · entry 2 Ceesay Abraham · CIK 0001722140 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By Dorothy Ceesay Irrevocable Trust Disclosed balance after: 25,812 F1 · kind: These transactions were effected by the Reporting Person pursuant to Rule 10b5-1 trading plans adopted on December 12, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.83 to $26.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. F4 · ownership.nature: Shares held by The Dorothy Ceesay Irrevocable Trust u/d/t dated March 27, 2024. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that he is a beneficial owner of such shares for the purpose of Section 16 of the Exchange Act, or for any other purpose. Read SEC document |
| January 20, 2026 Filed Jan 23, 2026 00:00 UTC |
Ceesay AbrahamDirector · Chief Executive Officer
|
SaleCommon Stock | 5,833 | $26.12 | $152,333.46 |
DisclosureSEC source: 0001193125-26-019820 · ownership.xml · nonDerivative · entry 1 Ceesay Abraham · CIK 0001722140 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 562,080 F1 · kind: These transactions were effected by the Reporting Person pursuant to Rule 10b5-1 trading plans adopted on December 12, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.83 to $26.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. Read SEC document |
| January 15, 2026 Filed Jan 16, 2026 16:06 UTC |
Bredt DavidChief Scientific Officer
|
SaleCommon Stock | 200 | $27.40 | $5,480.00 |
DisclosureSEC source: 0001193125-26-015350 · ownership.xml · nonDerivative · entry 2 Bredt David · CIK 0002022087 · Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 395,575 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 12, 2024. Read SEC document |
| January 15, 2026 Filed Jan 16, 2026 16:06 UTC |
Bredt DavidChief Scientific Officer
|
SaleCommon Stock | 8,300 | $26.83 | $222,651.65 |
DisclosureSEC source: 0001193125-26-015350 · ownership.xml · nonDerivative · entry 1 Bredt David · CIK 0002022087 · Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 395,775 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 12, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.33 to $27.30, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. Read SEC document |
| December 31, 2025 Filed Jan 5, 2026 16:20 UTC |
Bredt DavidChief Scientific Officer
|
SaleCommon Stock | 6,567 | $30.05 | $197,337.69 |
DisclosureSEC source: 0001193125-26-002470 · ownership.xml · nonDerivative · entry 2 Bredt David · CIK 0002022087 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 404,075 F2 · kind: Represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units, and does not represent a discretionary trade by the reporting person. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.04 to $30.05. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| December 31, 2025 Filed Jan 5, 2026 16:20 UTC |
Bredt DavidChief Scientific Officer
|
GrantCommon Stock | 18,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-002470 · ownership.xml · nonDerivative · entry 1 Bredt David · CIK 0002022087 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 410,642 F1 · price: On December 4, 2024, the Reporting Person was granted performance-based restricted stock units ("PSUs") subject to the satisfaction of specified performance criteria as of December 31, 2025. The issuers Compensation Committee confirmed that the performance criteria had been met, resulting in the vesting of such PSUs effective December 31, 2025. Read SEC document |
| December 31, 2025 Filed Jan 5, 2026 21:19 UTC |
Yeleswaram KrishnaswamyChief Development Officer
|
SaleCommon Stock | 2,840 | $30.05 | $85,342.00 |
DisclosureSEC source: 0001193125-26-002469 · ownership.xml · nonDerivative · entry 2 Yeleswaram Krishnaswamy · CIK 0002022156 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 296,991 F2 · kind: Represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units, and does not represent a discretionary trade by the reporting person. Read SEC document |
| December 31, 2025 Filed Jan 5, 2026 21:19 UTC |
Yeleswaram KrishnaswamyChief Development Officer
|
GrantCommon Stock | 9,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-002469 · ownership.xml · nonDerivative · entry 1 Yeleswaram Krishnaswamy · CIK 0002022156 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 299,831 F1 · kind: On December 4, 2024, the Reporting Person was granted performance-based restricted stock units ("PSUs") subject to the satisfaction of specified performance criteria as of December 31, 2025. The issuers Compensation Committee confirmed that the performance criteria had been met, resulting in the vesting of such PSUs effective December 31, 2025. F1 · price: On December 4, 2024, the Reporting Person was granted performance-based restricted stock units ("PSUs") subject to the satisfaction of specified performance criteria as of December 31, 2025. The issuers Compensation Committee confirmed that the performance criteria had been met, resulting in the vesting of such PSUs effective December 31, 2025. Read SEC document |
| December 17, 2025 Filed Dec 18, 2025 21:11 UTC |
Ceesay AbrahamDirector · Chief Executive Officer
|
SaleCommon Stock | 515 | $31.04 | $15,985.39 |
DisclosureSEC source: 0001193125-25-324826 · ownership.xml · nonDerivative · entry 6 Ceesay Abraham · CIK 0001722140 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By Dorothy Ceesay Irrevocable Trust Disclosed balance after: 30,895 F1 · kind: These transactions were effected by the Reporting Person pursuant to Rule 10b5-1 trading plans adopted on December 12, 2024. F7 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.75 to $31.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. F8 · ownership.nature: Shares held by The Dorothy Ceesay Irrevocable Trust u/d/t dated March 27, 2024. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that he is a beneficial owner of such shares for the purpose of Section 16 of the Exchange Act, or for any other purpose. Read SEC document |
| December 17, 2025 Filed Dec 18, 2025 21:11 UTC |
Ceesay AbrahamDirector · Chief Executive Officer
|
SaleCommon Stock | 2,421 | $30.04 | $72,721.51 |
DisclosureSEC source: 0001193125-25-324826 · ownership.xml · nonDerivative · entry 5 Ceesay Abraham · CIK 0001722140 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By Dorothy Ceesay Irrevocable Trust Disclosed balance after: 31,410 F1 · kind: These transactions were effected by the Reporting Person pursuant to Rule 10b5-1 trading plans adopted on December 12, 2024. F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $29.72 to $30.61, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. F8 · ownership.nature: Shares held by The Dorothy Ceesay Irrevocable Trust u/d/t dated March 27, 2024. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that he is a beneficial owner of such shares for the purpose of Section 16 of the Exchange Act, or for any other purpose. Read SEC document |
| December 17, 2025 Filed Dec 18, 2025 21:11 UTC |
Ceesay AbrahamDirector · Chief Executive Officer
|
SaleCommon Stock | 2,147 | $28.84 | $61,924.85 |
DisclosureSEC source: 0001193125-25-324826 · ownership.xml · nonDerivative · entry 4 Ceesay Abraham · CIK 0001722140 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By Dorothy Ceesay Irrevocable Trust Disclosed balance after: 33,831 F1 · kind: These transactions were effected by the Reporting Person pursuant to Rule 10b5-1 trading plans adopted on December 12, 2024. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.62 to $29.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. F8 · ownership.nature: Shares held by The Dorothy Ceesay Irrevocable Trust u/d/t dated March 27, 2024. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that he is a beneficial owner of such shares for the purpose of Section 16 of the Exchange Act, or for any other purpose. Read SEC document |
| December 17, 2025 Filed Dec 18, 2025 21:11 UTC |
Ceesay AbrahamDirector · Chief Executive Officer
|
SaleCommon Stock | 600 | $31.04 | $18,621.60 |
DisclosureSEC source: 0001193125-25-324826 · ownership.xml · nonDerivative · entry 3 Ceesay Abraham · CIK 0001722140 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 567,913 F1 · kind: These transactions were effected by the Reporting Person pursuant to Rule 10b5-1 trading plans adopted on December 12, 2024. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.78 to $31.12, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. Read SEC document |
| December 17, 2025 Filed Dec 18, 2025 21:11 UTC |
Ceesay AbrahamDirector · Chief Executive Officer
|
SaleCommon Stock | 2,792 | $30.04 | $83,861.91 |
DisclosureSEC source: 0001193125-25-324826 · ownership.xml · nonDerivative · entry 2 Ceesay Abraham · CIK 0001722140 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 568,513 F1 · kind: These transactions were effected by the Reporting Person pursuant to Rule 10b5-1 trading plans adopted on December 12, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $29.72 to $30.72 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. Read SEC document |
| December 17, 2025 Filed Dec 18, 2025 21:11 UTC |
Ceesay AbrahamDirector · Chief Executive Officer
|
SaleCommon Stock | 2,441 | $28.84 | $70,393.07 |
DisclosureSEC source: 0001193125-25-324826 · ownership.xml · nonDerivative · entry 1 Ceesay Abraham · CIK 0001722140 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 571,305 F1 · kind: These transactions were effected by the Reporting Person pursuant to Rule 10b5-1 trading plans adopted on December 12, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.62 to $29.49, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. Read SEC document |
| December 15, 2025 Filed Dec 16, 2025 17:07 UTC |
Bredt DavidChief Scientific Officer
|
SaleCommon Stock | 796 | $30.68 | $24,419.05 |
DisclosureSEC source: 0001193125-25-321142 · ownership.xml · nonDerivative · entry 2 Bredt David · CIK 0002022087 · Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 392,642 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 12, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.61 to $30.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. Read SEC document |
| December 15, 2025 Filed Dec 16, 2025 17:07 UTC |
Bredt DavidChief Scientific Officer
|
SaleCommon Stock | 7,704 | $29.95 | $230,710.92 |
DisclosureSEC source: 0001193125-25-321142 · ownership.xml · nonDerivative · entry 1 Bredt David · CIK 0002022087 · Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 393,438 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 12, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $29.58 to $30.57, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. Read SEC document |
| November 26, 2025 Filed Dec 1, 2025 21:17 UTC |
Gault CherylChief Operating Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $1.80 | $0.00 |
DisclosureSEC source: 0001193125-25-303910 · ownership.xml · derivative · entry 3 Gault Cheryl · CIK 0001839046 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 105,407 Underlying: Common Stock · 5,000 shares Expires 2033-12-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 11, 2024. F3 · derivative.exercise_date: 25% of the shares underlying this option vested and became exercisable on August 7, 2024, with the remaining shares vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| November 26, 2025 Filed Dec 1, 2025 21:17 UTC |
Gault CherylChief Operating Officer
|
SaleCommon Stock | 5,000 | $30.10 | $150,486.50 |
DisclosureSEC source: 0001193125-25-303910 · ownership.xml · nonDerivative · entry 2 Gault Cheryl · CIK 0001839046 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 171,928 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 11, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.00 to $30.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. Read SEC document |
| November 26, 2025 Filed Dec 1, 2025 21:17 UTC |
Gault CherylChief Operating Officer
|
Exercise / conversionCommon Stock | 5,000 | $1.80 | $9,000.00 |
DisclosureSEC source: 0001193125-25-303910 · ownership.xml · nonDerivative · entry 1 Gault Cheryl · CIK 0001839046 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 176,928 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 11, 2024. Read SEC document |
| November 17, 2025 Filed Nov 18, 2025 16:24 UTC |
Bredt DavidChief Scientific Officer
|
SaleCommon Stock | 5,344 | $25.39 | $135,695.92 |
DisclosureSEC source: 0001193125-25-286212 · ownership.xml · nonDerivative · entry 2 Bredt David · CIK 0002022087 · Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 401,142 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 12, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.16 to $25.77, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. Read SEC document |
| November 17, 2025 Filed Nov 18, 2025 16:24 UTC |
Bredt DavidChief Scientific Officer
|
SaleCommon Stock | 3,156 | $24.84 | $78,394.72 |
DisclosureSEC source: 0001193125-25-286212 · ownership.xml · nonDerivative · entry 1 Bredt David · CIK 0002022087 · Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 406,486 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 12, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.16 to $25.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. Read SEC document |
| November 17, 2025 Filed Nov 18, 2025 21:27 UTC |
Ceesay AbrahamDirector · Chief Executive Officer
|
SaleCommon Stock | 2,841 | $25.44 | $72,266.52 |
DisclosureSEC source: 0001193125-25-286218 · ownership.xml · nonDerivative · entry 4 Ceesay Abraham · CIK 0001722140 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By Dorothy Ceesay Irrevocable Trust Disclosed balance after: 35,978 F1 · kind: These transactions were effected by the Reporting Person pursuant to Rule 10b5-1 trading plans adopted on December 12, 2024. F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.23 to $25.74, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. F5 · ownership.nature: Shares held by The Dorothy Ceesay Irrevocable Trust u/d/t dated March 27, 2024. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that he is a beneficial owner of such shares for the purpose of Section 16 of the Exchange Act, or for any other purpose. Read SEC document |
| November 17, 2025 Filed Nov 18, 2025 21:27 UTC |
Ceesay AbrahamDirector · Chief Executive Officer
|
SaleCommon Stock | 2,242 | $24.91 | $55,849.79 |
DisclosureSEC source: 0001193125-25-286218 · ownership.xml · nonDerivative · entry 3 Ceesay Abraham · CIK 0001722140 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By Dorothy Ceesay Irrevocable Trust Disclosed balance after: 38,819 F1 · kind: These transactions were effected by the Reporting Person pursuant to Rule 10b5-1 trading plans adopted on December 12, 2024. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.21 to $25.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. F5 · ownership.nature: Shares held by The Dorothy Ceesay Irrevocable Trust u/d/t dated March 27, 2024. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that he is a beneficial owner of such shares for the purpose of Section 16 of the Exchange Act, or for any other purpose. Read SEC document |
| November 17, 2025 Filed Nov 18, 2025 21:27 UTC |
Ceesay AbrahamDirector · Chief Executive Officer
|
SaleCommon Stock | 3,056 | $25.43 | $77,715.00 |
DisclosureSEC source: 0001193125-25-286218 · ownership.xml · nonDerivative · entry 2 Ceesay Abraham · CIK 0001722140 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 573,746 F1 · kind: These transactions were effected by the Reporting Person pursuant to Rule 10b5-1 trading plans adopted on December 12, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.22 to $25.68 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. Read SEC document |
| November 17, 2025 Filed Nov 18, 2025 21:27 UTC |
Ceesay AbrahamDirector · Chief Executive Officer
|
SaleCommon Stock | 2,777 | $24.92 | $69,215.61 |
DisclosureSEC source: 0001193125-25-286218 · ownership.xml · nonDerivative · entry 1 Ceesay Abraham · CIK 0001722140 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 576,802 F1 · kind: These transactions were effected by the Reporting Person pursuant to Rule 10b5-1 trading plans adopted on December 12, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.22 to $25.21, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. Read SEC document |
| October 15, 2025 Filed Oct 16, 2025 16:30 UTC |
Bredt DavidChief Scientific Officer
|
SaleCommon Stock | 1,082 | $26.16 | $28,309.56 |
DisclosureSEC source: 0001193125-25-241475 · ownership.xml · nonDerivative · entry 2 Bredt David · CIK 0002022087 · Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 409,642 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 12, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.07 to $26.36, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. Read SEC document |
| October 15, 2025 Filed Oct 16, 2025 16:30 UTC |
Bredt DavidChief Scientific Officer
|
SaleCommon Stock | 7,418 | $25.73 | $190,886.65 |
DisclosureSEC source: 0001193125-25-241475 · ownership.xml · nonDerivative · entry 1 Bredt David · CIK 0002022087 · Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 410,724 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 12, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.07 to $26.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. Read SEC document |
| October 15, 2025 Filed Oct 16, 2025 20:30 UTC |
Ceesay AbrahamDirector · Chief Executive Officer
|
SaleCommon Stock | 755 | $26.17 | $19,759.94 |
DisclosureSEC source: 0001193125-25-241472 · ownership.xml · nonDerivative · entry 4 Ceesay Abraham · CIK 0001722140 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By Dorothy Ceesay Irrevocable Trust Disclosed balance after: 41,061 F1 · kind: These transactions were effected by the Reporting Person pursuant to Rule 10b5-1 trading plans adopted on December 12, 2024. F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.08 to $26.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. F5 · ownership.nature: Shares held by The Dorothy Ceesay Irrevocable Trust u/d/t dated March 27, 2024. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that he is a beneficial owner of such shares for the purpose of Section 16 of the Exchange Act, or for any other purpose. Read SEC document |
| October 15, 2025 Filed Oct 16, 2025 20:30 UTC |
Ceesay AbrahamDirector · Chief Executive Officer
|
SaleCommon Stock | 4,328 | $25.75 | $111,428.69 |
DisclosureSEC source: 0001193125-25-241472 · ownership.xml · nonDerivative · entry 3 Ceesay Abraham · CIK 0001722140 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By Dorothy Ceesay Irrevocable Trust Disclosed balance after: 41,816 F1 · kind: These transactions were effected by the Reporting Person pursuant to Rule 10b5-1 trading plans adopted on December 12, 2024. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.07 to $26.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. F5 · ownership.nature: Shares held by The Dorothy Ceesay Irrevocable Trust u/d/t dated March 27, 2024. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that he is a beneficial owner of such shares for the purpose of Section 16 of the Exchange Act, or for any other purpose. Read SEC document |
| October 15, 2025 Filed Oct 16, 2025 20:30 UTC |
Ceesay AbrahamDirector · Chief Executive Officer
|
SaleCommon Stock | 1,186 | $26.14 | $31,001.09 |
DisclosureSEC source: 0001193125-25-241472 · ownership.xml · nonDerivative · entry 2 Ceesay Abraham · CIK 0001722140 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 579,579 F1 · kind: These transactions were effected by the Reporting Person pursuant to Rule 10b5-1 trading plans adopted on December 12, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.06 to $26.42 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. Read SEC document |
| October 15, 2025 Filed Oct 16, 2025 20:30 UTC |
Ceesay AbrahamDirector · Chief Executive Officer
|
SaleCommon Stock | 4,647 | $25.72 | $119,539.43 |
DisclosureSEC source: 0001193125-25-241472 · ownership.xml · nonDerivative · entry 1 Ceesay Abraham · CIK 0001722140 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 580,765 F1 · kind: These transactions were effected by the Reporting Person pursuant to Rule 10b5-1 trading plans adopted on December 12, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.06 to $26.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. Read SEC document |
| September 17, 2025 Filed Sep 19, 2025 20:05 UTC |
Ceesay AbrahamDirector · Chief Executive Officer
|
SaleCommon Stock | 700 | $27.04 | $18,930.03 |
DisclosureSEC source: 0001193125-25-209062 · ownership.xml · nonDerivative · entry 4 Ceesay Abraham · CIK 0001722140 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By Dorothy Ceesay Irrevocable Trust Disclosed balance after: 46,144 F1 · kind: These transactions were effected by the Reporting Person pursuant to Rule 10b5-1 trading plans adopted on December 12, 2024. F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.02 to $27.17, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. F5 · ownership.nature: Shares held by The Dorothy Ceesay Irrevocable Trust u/d/t dated March 27, 2024. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that he is a beneficial owner of such shares for the purpose of Section 16 of the Exchange Act, or for any other purpose. Read SEC document |
| September 17, 2025 Filed Sep 19, 2025 20:05 UTC |
Ceesay AbrahamDirector · Chief Executive Officer
|
SaleCommon Stock | 34,885 | $26.30 | $917,541.78 |
DisclosureSEC source: 0001193125-25-209062 · ownership.xml · nonDerivative · entry 3 Ceesay Abraham · CIK 0001722140 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By Dorothy Ceesay Irrevocable Trust Disclosed balance after: 46,844 F1 · kind: These transactions were effected by the Reporting Person pursuant to Rule 10b5-1 trading plans adopted on December 12, 2024. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.78 to $26.74, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. F5 · ownership.nature: Shares held by The Dorothy Ceesay Irrevocable Trust u/d/t dated March 27, 2024. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that he is a beneficial owner of such shares for the purpose of Section 16 of the Exchange Act, or for any other purpose. Read SEC document |
| September 17, 2025 Filed Sep 19, 2025 20:05 UTC |
Ceesay AbrahamDirector · Chief Executive Officer
|
SaleCommon Stock | 1,400 | $26.87 | $37,624.30 |
DisclosureSEC source: 0001193125-25-209062 · ownership.xml · nonDerivative · entry 2 Ceesay Abraham · CIK 0001722140 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 585,412 F1 · kind: These transactions were effected by the Reporting Person pursuant to Rule 10b5-1 trading plans adopted on December 12, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.74 to $27.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.